Skip to content
Application 207407
- Type
- ANDA
- Sponsor
- LANNETT CO INC
Application Products#
Product, Drug, Ingredient table| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|
| 001 | LOPINAVIR AND RITONAVIR | LOPINAVIR; RITONAVIR | SOLUTION;ORAL | 80MG/ML;20MG/ML | No | No |
NDC Listings For This Application#
NDC, Name, Nonproprietary name table| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|
| 0527-1947 | Lopinavir-Ritonavir | Lopinavir-Ritonavir | Lannett Company, Inc. | ANDA | Current |
| 0527-1947 | Lopinavir-Ritonavir | Lopinavir-Ritonavir | Lannett Company, Inc. | ANDA | Current |
| 0527-1947 | Lopinavir-Ritonavir | Lopinavir-Ritonavir | Lannett Company, Inc. | ANDA | Current |
| 0527-1947 | Lopinavir-Ritonavir | Lopinavir-Ritonavir | Lannett Company, Inc. | ANDA | Current |
| 0527-1947 | Lopinavir-Ritonavir | Lopinavir-Ritonavir | Lannett Company, Inc. | ANDA | Current |
| 0527-1947 | Lopinavir-Ritonavir | Lopinavir-Ritonavir | Lannett Company, Inc. | ANDA | Current |
Documents#
Document, Submission type, Date table| Document | Submission type | Date |
|---|
| 47077 | ORIG | 2017-01-31 |
| 46585 | ORIG | 2016-12-29 |